home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
  HUM-MOLGEN -> Events -> Meetings and Conferences
Search  -  prev / next
 
 

Best Practices for Successful Execution of Radiopharmaceutical Clinical Trials

 
  January 30, 2025  
     
 
Xtalks, Online
2025-02-24


This webinar will provide an overview of evolving field of radiopharmaceuticals in the treatment of cancer, the complexities of radiopharmaceutical trials, and the considerations that are needed to successfully execute them.

Some of these considerations include drug manufacturing and distribution logistics, site feasibility, patient recruitment, operations management and regulatory considerations. The expert speakers will review these key areas and provide advice on how to manage them successfully.

The demand to treat patients with radioligand therapy (RLT) is anticipated to grow, in order to treat aggressive cancers to help improve survival and quality of life.

Register for this webinar to explore the complexities of radiopharmaceutical trials from drug manufacturing and distribution logistics to site feasibility, patient recruitment and regulatory considerations.

Keywords: Clinical Trials, Clinical Trial, Drug Development, Clinical Research, CRO, Drug Manufacturing, Logistics, Radiopharmaceuticals, Sites, Supply Chain/Logistics, Radioligands
 
 
Organized by: Xtalks
Invited Speakers: Binh Nguyen, MD-PhD, VP, Medical Science and Strategy, Clinical Research, Thermo Fisher Scientific
Justin Martin, PMP, Oversight Director, Project Delivery, Hematology/Oncology, Clinical Research Group (CRG), a part of Thermo Fisher Scientific
Erin Schaller, Associate Director – Cell & Gene Therapy, Global Clinical Supplies Client & Portfolio Manager, Clinical Research Group (CRG), a part of Thermo Fisher Scientific
Anne Gold, Project Oversight Director, Clinical Research, Thermo Fisher Scientific
Heather Horne, Project Mgr Director, Clinical Research, Thermo Fisher Scientific
David Rhein, PharmD, Associate Director, Regulatory Affairs, Thermo Fisher Scientific
 
Deadline for Abstracts: 2025-02-24
 
Registration: Free Registration
E-mail: tristan@xtalks.com
 
 
   
 
home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
 
 

Generated by meetings and positions 5.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995-2025 HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.